Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products (NASDAQ:UTMD) has declared a quarterly cash dividend of $.285 per share, to be paid on April 2, 2021, to shareholders on record by March 17, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Utah Medical Products (NASDAQ:UTMD) has declared a quarterly cash dividend of $.285 per share, to be paid on April 2, 2021, to shareholders on record by March 17, 2021. This dividend reflects a 2% increase compared to the previous year’s quarter. The company remains focused on providing medical devices in the women's health sector, recognized for their quality by clinicians in over 100 countries.
Positive
- Quarterly cash dividend increased by 2% to $.285 per share.
- Dividend payment indicates company confidence and commitment to returning income to shareholders.
- Strong global recognition of products in over 100 countries, which may support long-term growth.
Negative
- None.
Details
News Market Reaction – UTMD
The recorded move for UTMD in the trading session of this news was -0.02%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESSWIRE / February 9, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on April 2, 2021 to shareholders of record at the close of business on March 17, 2021. This is about a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
CONTACT:
Crystal Rios
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View source version on accesswire.com:
https://www.accesswire.com/628506/Utah-Medical-Products-Inc-Announces-Quarterly-Dividend
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.